Fibrobiologics Inc (FBLG)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1.81+2.84%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · FBLG
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | |
|---|---|---|---|---|---|---|
| Operating Expenses & Income | ||||||
| R&D Expenses | 8.2 | 7.4 | 4.5 | 2.4 | 1.1 | — |
| Operating Income | (16.7) | (16.6) | (13.7) | (8.9) | (4.5) | — |
| Earnings from Continuing Operations | ||||||
| Interest Expense | — | — | — | 0.1 | 0.7 | — |
| Interest & Investment Income | 0.1 | 0.2 | 0.3 | — | — | — |
| Other Non-Operating Income / Expenses | (1.4) | (2.0) | — | (0.2) | — | — |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | — |
| Net Income | ||||||
| Net Income | (18.1) | (18.6) | (11.2) | (16.5) | (5.1) | — |
| Per Share | ||||||
| Basic EPS | (2.89) | (0.42) | (0.34) | (0.68) | (0.18) | — |
| Diluted EPS | (2.89) | (0.42) | (0.34) | (0.68) | (0.18) | — |
| Basic Weighted Avg Shares | 6.3 | 44.7 | 32.9 | 28.2 | 28.2 | — |
| Diluted Weighted Avg Shares | 6.3 | 44.7 | 32.9 | 28.2 | 28.2 | — |
| Supplemental | ||||||
| EBIT | (16.7) | (16.6) | (13.7) | (8.9) | (4.5) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.